biomarker

Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer
Hiroaki Komatsu, Tetsuro Oishi, Hiroaki Itamochi, Muneaki Shimada, Shinya Sato, Jun Chikumi, Seiya Sato, Michiko Nonaka, Mayumi Sawada, Makoto Wakahara, Yoshihisa Umekita, Tasuku Harada

International Journal of Gynecologic Cancer Sep 2017, 27 (7) 1325-1332; DOI: 10.1097/IGC.0000000000001027
PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies
Ting Luan, Quan Hua, Xia Liu, Pengfei Xu, Yun Gu, Hua Qian, Lina Yan, Xueqin Xu, Rong Geng, Xin Zeng, Ping Li

International Journal of Gynecologic Cancer Sep 2017, 27 (7) 1480-1488; DOI: 10.1097/IGC.0000000000001011
Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results
Steffen Böhm, Nhu Le, Michelle Lockley, Elly Brockbank, Asma Faruqi, Ian Said, Arjun Jeyarajah, Rekha Wuntakal, Blake Gilks, Naveena Singh

International Journal of Gynecologic Cancer Feb 2019, 29 (2) 353-356; DOI: 10.1136/ijgc-2018-000092
The Prognostic Value of Plasma YKL-40 in Patients With Chemotherapy-Resistant Ovarian Cancer Treated With Bevacizumab
Mogens K. Boisen, Christine V. Madsen, Christian Dehlendorff, Anders Jakobsen, Julia S. Johansen, Karina D. Steffensen

International Journal of Gynecologic Cancer Oct 2016, 26 (8) 1390-1398; DOI: 10.1097/IGC.0000000000000798
Diagnostic Value of Total Plasma Lysophosphatidic Acid in Ovarian Cancer: A Meta-analysis
Zhaolian Lu, Yingjian Chen, Zhide Hu, Chengjin Hu

International Journal of Gynecologic Cancer Jan 2015, 25 (1) 18-23; DOI: 10.1097/IGC.0000000000000319
Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma
Divya Gupta, Marc J. Gunter, Kathleen Yang, Stephen Lee, Lisa Zuckerwise, Lee-may Chen, Gary L. Goldberg, Gloria S. Huang

International Journal of Gynecologic Cancer Apr 2011, 21 (3) 529-534; DOI: 10.1097/IGC.0b013e31821091b5
Ovarian Cancer: The Role of Functional Imaging as an End Point in Clinical Trials
Evis Sala, Nandita DeSouza, Susanna I. Lee, Mostafa Atri, Hedvig Hricak

International Journal of Gynecologic Cancer Jul 2010, 20 (6) 971-978; DOI: 10.1111/IGC.0b013e3181e0a353
Claudin 10 Is a Glandular Epithelial Marker in the Chicken Model as Human Epithelial Ovarian Cancer
Hee Won Seo, Deivendran Rengaraj, Jin Won Choi, Suzie E. Ahn, Yong Sang Song, Gwonhwa Song, Jae Yong Han

International Journal of Gynecologic Cancer Nov 2010, 20 (9) 1465-1473; DOI: 10.1111/IGC.0b013e3181fb18e4
Proteomic analysis for early detection of ovarian cancer: A realistic approach?
E. V. Stevens, L. A. Liotta, E. C. Kohn

International Journal of Gynecologic Cancer Oct 2003, 13 (Suppl 2) 133-139; DOI: 10.1136/ijgc-00009577-200311001-00001
MYBL2 (B-MYB) in Cervical Cancer: Putative Biomarker
Katharine Astbury, Lynda McEvoy, Hayes Brian, Cathy Spillane, Orla Sheils, Cara Martin, John J. O'Leary

International Journal of Gynecologic Cancer Jan 2011, 21 (2) 206-212; DOI: 10.1097/IGC.0b013e318205759f

Main menu

biomarker

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarker

Pages